Determinants of quinolone resistance in Escherichia coli causing community-acquired urinary tract infection in Bejaia, Algeria

Asian Pacific Journal of Tropical Medicine

Volumn 7, Issue 6, 2014, Pages 462-467

  Betitra, Yanat ^a,b   Teresa, Vinuesa ^b   Miguel, Viñas ^b   Abdelaziz, Touati ^a  

^a UNIVERSITY OF BEJAIA   (Algeria)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Community acquired urinary tract infection; ESBL; Escherichia coli; Qnr; QRDR

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE TEM 1; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; IMIPENEM; KANAMYCIN; NALIDIXIC ACID; OFLOXACIN; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ALGERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BLA CTX M GENE; BLA TEM GENE; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; GENE MUTATION; GYRA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARC GENE; PRIORITY JOURNAL; QNRA GENE; QNRB GENE; QNRS GENE; URINARY TRACT INFECTION; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; URINARY TRACT INFECTIONS;

ALGERIA; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; QUINOLONES; URINARY TRACT INFECTIONS;

EID: 84904615910     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(14)60075-4     Document Type: Article

References (34)

1. Lobel B, Valot A, Cattoir V, Lemenand O, Gaillot O Comparison antimicrobial susceptibility of 1 217 Escherichia coli isolates from women with hospital and community-acquired urinary tract infections. Presse Med 2008, 37:746-750. (In French.).
2. Paton JH, Reeves DS Fluoroquinolones antibiotics. Microbiology, pharmacocinetiks and clinical use. Drugs 1988, 36:193-228.
3. Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, et al. Emergence of fluoroquinolones resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008, 121:876-884.
4. Kim JY, Jeon SM, Kim H, Lin N, Park MS, Kim SH Resistance to fluroquinolone by a combination of efflux and target site mutations in Enteroaggregative Escherichia coli isolated in Korea. Osong Public Health Res Perspect 2012, 3(4):239-244.
5. Martínez-Martínez L, Pascual A, Jacoby GA Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
6. Hata M, Suzuki M, Matsumoto M, Takahashi M, Sato K, Ibe S, et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005, 49:801-803.
7. Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A, et al. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 2006, 50:1178-1182.
8. Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S, et al. New plasmid-mediated quinolone resistance gene, qnrC1, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 2009, 53:1892-1897.
9. Cavaco LM, Hasman H, Xia S, Aarestrup FM qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enteric serovars Kentucky and Bovismorbificans of human origin. Antimicrob Agents Chemother 2009, 53:603-608.
10. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nature Med 2006, 12(1):83-88.
11. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 2007, 51(9):3354-3360.
12. Hansen LH, Johannesen E, Burmølle M, Sørensen AH, Sørensen SJ Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 2004, 48:3332-3337.
13. Messai Y, Iabadene H, Benhassine T, Alouache S, Tazir M, Gautier V, et al. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol Biol 2008, 56:319-325.
14. Meradi L, Djahoudi A, Abdi A, Bouchakour M, Gros Perrier, Claude JD, et al. Qnr and aac(6')-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria. Pathol Biol 2011, 59:73-78. (in French).
15. Amin AK, Warehama DW Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK. Int J Antimicrob Agents 2009, 34:490-503.
16. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: Twenty-first informational supplement M100-S21 2011, CLSI, Wayne.
17. Jarlier V, Nicolas MH, Fournier G, Philippon A Extended broad-spectrum-beta-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Infect Dis Rev 1988, 10:867-878.
18. Berlanga M, Vázquez JL, Hernandez-Borrell J, Montero MT, Viñas M Evidence of an efflux pump in Serratia marcescens. Microb Drug Resist 2000, 6(2):111-117.
19. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC Qnr Prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006, 50:2872-2874.
20. Brasme L, Nordmann P, Fidel F, Lartigue MF, Bajolet O, Poirel L, et al. Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J Antimicrob Chemother 2007, 60:956-964.
21. Morgan-Linnell SK, Boyd LB, Steffen D, Zechiedrich L Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob Agents Chemother 2009, 53(1):235-242.
22. Minarini LA, Darini AL Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from brazil. Braz J Microbiol 2012, 42(4):1309-1314.
23. Bansal S, Tandon V Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. Int J Antimicrob Agents 2011, 37:253-255.
24. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A Plasmid-mediated quinolone Resistance: a multifaceted threat. Clinical Microbiology Rev 2009, 22:664-689.
25. Touati A, Brasme L, Benallaoua S, Gharout A, Madoux J, De Champs C First report of qnrB-producing E. cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagn Microbiol Infect Dis 2008, 60:287-290.
26. Zhao X, Xu X, Zhu D, Ye X, Wang M Decreased quinolone susceptibility in high percentage of E. cloacae clinical isolates caused only by Qnr determinants. Diagn Microbiol Infect Dis 2010, 67:110-113.
27. Rodriguez-Martinez JM, Velasco C, Garcia I, Cano ME, Martinez-Martinez L, Pascual A Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother 2007, 51:2236-2239.
28. Briales A, Rodríguez-Martínez JM, Velasco C, Díaz de Alba P, Dominguez-Herrera J, Pachon J, et al. In vitro effect of qnrA1, qnrB1 and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. Antimicrob Agents Chemother 2011, 55(3):1266-1269.
29. Olson RP, Harrell LJ, Kaye KS Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother 2009, 53(3):1285-1286.
30. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000, 14:137-142.
31. CTX-M15 in a French intensive care unit. Annof Intensive Care 2013, 3(1):18-22.
32. Deepak RN, Koh TH, Chan KS Plasmid-mediated quinolone resistance determinants in urinary isolates of Escherichia coli and Klebsiella pneumoniae in a large Singapore hospital. Ann Acad Med Singapore 2009, 38:1070-1073.
33. Fang H, Huang H, Shi Y, Hedin G, Nord CE, Ullberg M Prevalence of qnr determinants among extended-spectrum β-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden. Int J Antimicrob Agents 2009, 34:268-270.
34. Bouchakour M, Zerouali K, Gros Claude JDP, Amarouch H, El Mdaghri N, Courvalin P, et al. Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing Enterobacteriaceae in Morocco. J Infect Dev Ctries 2010, 4(12):799-803.